Skip to content
Press Release

SOMAÍ Pharmaceuticals has renewed the partnership with Lusófona University/CBIOS for formulation development

Jul. 26, 2023 by SOMAÍ

According to this partnership, Lusófona will develop lab-scale formulations and perform corresponding stability testing. The collaboration will also encompass “In Vitro,” “In Vivo” (animal model), and finely-tuned “In Human” absorption studies. To ensure the successful execution of these studies, a team of skilled human resources will be provided to offer comprehensive support and oversight.

This collaboration aims to leverage the expertise of both SOMAÍ Pharmaceuticals and Lusófona University in the pursuit of advancements in formulation development.